Literature DB >> 33528304

Differential Diagnosis of Endolymphatic Hydrops Between "Probable" and "Definite" Ménière's Disease via Magnetic Resonance Imaging.

Jiapei Xie1, Weidong Zhang2, Jingyi Zhu2, Lian Hui3, Songbai Li2, Ling Ren2, Fei Wang3, Bo Zhang2.   

Abstract

OBJECTIVES: To investigate the grade of endolymphatic hydrops in patients with "probable" and "definite" Ménière's disease via magnetic resonance imaging (MRI) and to determine whether MRI could assist clinicians in differential diagnosis between probable and definite Ménière's disease. STUDY
DESIGN: Prospective study.
SETTING: Three-dimensional FLAIR MRI (fluid-attenuated inversion recovery) to examine endolymphatic hydrops in Ménière's disease.
METHODS: A total of 51 patients diagnosed with probable (n = 20) or definite (n = 31) unilateral Ménière's disease were enrolled. Three-dimensional FLAIR MRI was performed to evaluate the grade of endolymphatic hydrops. The differences in endolymphatic hydrops between the probable and definite groups were analyzed.
RESULTS: The grade of endolymphatic hydrops was more severe in the definite group than in the probable group (P < .05).
CONCLUSION: MRI revealed a higher grade of endolymphatic hydrops in patients with definite Ménière's disease than in patients with probable Ménière's disease. As a result, it may be clinically useful and an effective tool in the differentiation between definite and probable Ménière's disease.

Entities:  

Keywords:  Ménière’s disease; diagnostic criteria; endolymphatic hydrops; grades; magnetic resonance imaging

Year:  2021        PMID: 33528304     DOI: 10.1177/0194599821990680

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Correlation of clinical parameters with endolymphatic hydrops on MRI in Meniere's disease.

Authors:  Seung Cheol Han; Young Seok Kim; Yehree Kim; Sang-Yeon Lee; Jae-Jin Song; Byung Yoon Choi; Ji-Soo Kim; Yun Jung Bae; Ja-Won Koo
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.